BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33789373)

  • 1. [Transcriptome sequencing-based classification and quantification of IKZF1 transcript isoforms in B-cell acute lymphoblastic leukemia].
    Cao PX; Zhang GS; Wang F; Chen X; Zhang Y; Wang MY; Zhou XS; Nie DJ; Chen JQ; Ma XL; Fang JC; Liu M; Wu QS; Liu HX
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):926-933. PubMed ID: 33789373
    [No Abstract]   [Full Text] [Related]  

  • 2. High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia.
    Tokunaga K; Yamaguchi S; Iwanaga E; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N
    Eur J Haematol; 2013 Sep; 91(3):201-208. PubMed ID: 23751147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of IKZF1 gene IK6 isoform in adult acute lymphoblastic leukemia].
    Yuan T; Zhao XL; Zhang LX; Li QH; Tian Z; Tang KJ; Wang Y; Lin D; Li W; Liu BC; Zhou CL; Wang M; Wang JX; Mi YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):539-43. PubMed ID: 23815894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection by a simple and cheaper methodology of Ik6 and Ik10 isoforms of the IKZF1 gene is highly associated with a poor prognosis in B-lineage paediatric acute lymphoblastic leukaemia.
    Moreira LBP; Queiróz RP; Suazo VK; Perna E; Brandalise SR; Yunes JA; Tone LG; Scrideli CA
    Br J Haematol; 2019 Nov; 187(3):e58-e61. PubMed ID: 31483479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of minimal residual disease level on day 33 of remission induction and IKZF1 genotype on the survival of children with B-lineage acute lymphoblastic leukemia].
    Kuang WY; Zheng MC; Li WL; Yang HX; Zhang BS; Wu P
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):538-542. PubMed ID: 30022754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
    Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
    Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toblerone: detecting exon deletion events in cancer using RNA-seq.
    Lonsdale A; Halman A; Brown L; Kosasih H; Ekert P; Oshlack A
    F1000Res; 2023; 12():130. PubMed ID: 37767021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.
    Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M;
    Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Schieck M; Lentes J; Thomay K; Hofmann W; Behrens YL; Hagedorn M; Ebersold J; Davenport CF; Fazio G; Möricke A; Buchmann S; Alten J; Cario G; Schrappe M; Bergmann AK; Stanulla M; Steinemann D; Schlegelberger B; Cazzaniga G; Göhring G
    Ann Hematol; 2020 Apr; 99(4):809-818. PubMed ID: 32078009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Ikaros isoform 6 in chinese children with acute lymphoblastic leukemia.
    Zhou F; Mei H; Jin R; Li X; Chen X
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):429-32. PubMed ID: 21792038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
    Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G
    Blood; 2008 Nov; 112(9):3847-55. PubMed ID: 18650450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
    Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
    Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of
    Cui L; Gao C; Wang CJ; Zhao XX; Li WJ; Li ZG; Zheng HY; Wang TY; Zhang RD
    Leuk Lymphoma; 2021 Feb; 62(2):410-418. PubMed ID: 33054468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities.
    Rogers JH; Gupta R; Reyes JM; Gundry MC; Medrano G; Guzman A; Aguilar R; Conneely SE; Song T; Johnson C; Barnes S; Cristobal CDD; Kurtz K; Brunetti L; Goodell MA; Rau RE
    Blood Adv; 2021 Oct; 5(19):3876-3890. PubMed ID: 34492683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The abnormal expression of IKZF1 encoded protein-IKAROS in B-ALL children].
    Huang XH; Chen J; Li BS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):743-7. PubMed ID: 24034916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis.
    Huang Z; Jia Y; Ruan G; Zuo Y; Wu J; Lu A; Xue Y; Cheng Y; Zhang L
    Pediatr Hematol Oncol; 2022 Apr; 39(3):243-253. PubMed ID: 34582325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.